PharmaBoardroom

Artificial Intelligence Can Save Pharmacovigilance in Australia

Writing in the January edition of DIA’s Global Forum magazine, Julia Chan, David Liew, Jana Stojanova, and Chris McMaster of Austin Health,…

China: Emerging Pharmacovigilance Framework Ensuring Safe…

PPC China’s Sophia Duan, writing in the January edition of DIA’s Global Forum magazine, details how the emergence of an effective…

CAR-T and the Art of Managing Expectations

Chimeric antigen receptor (CAR-T) therapy was first approved by the US FDA back in 2017 amid a great deal of fanfare and high expectations among…

Saudi Arabia: A New Dawn for Women in Work

Before Crown Prince Mohammed bin Salman assumed office in 2017, Saudi Arabian women had only a marginal presence in the Kingdom’s labour force.…

Top 10 Fastest Growing Pharma Companies in MEA

The top 10 fastest growing pharma companies in the Middle East and Africa (region) ranked by previous period growth between MAT Q2 2020 and MAT Q2…

Carlos Rubió – Executive President, Laboratorios Rubió

The executive president of Laboratorios Rubió, Carlos Rubió, analyses the fundamentals behind the Catalan company’s double-digit growth, its…

China Pharma News: 61.7% Profit Hit Needed for NDRL Listing;…

Some of the biggest stories across China’s healthcare and life science industry today, including the 61.7 percent average price reduction Big Pharma…

West APAC VP & GM Stewart Campbell on Meeting Asian…

Stewart Campbell, vice president and general manager, Asia Pacific, West Pharmaceutical Services, highlights how the drug containment and delivery…

Africa’s Renewed Hope for Drug Discovery and Health Innovation

Kelly Chibale, founder of the H3D Centre at the University of Cape Town and chairman & CEO of the H3D Foundation, outlines the rationale behind…

Indian Pharma’s Five Fastest Growing Companies

The Indian pharma market clocked up double-digit growth of around 15 percent in 2021 (compared to three percent in 2020), driven primarily – but not…

5 Key Trends in Saudi Medtech

The Saudi medtech market was valued at USD 2.25 billion in 2017 and is expected to reach USD 3.87 billion at a CAGR of 9.5 percent by 2023, according…

Tamer Group: A Vision for the Future

Historic Saudi healthcare firm Tamer Group has transitioned from a distributor into one of the country’s leading fully-fledged pharmaceutical…

Tagged with